Entries by CAPTIS

4 False Beliefs About Networking in the Social Jungle

October 3, 2013 Banish these falsehoods from your thinking, and you’ll pave the way for effective networking. By Sandy Jones-Kaminski, Author of I’m at a Networking Event–Now What??? Since this is my first column for BioSpace.com, I thought it best to set the stage by reviewing–and debunking–what I’ve identified as a few common myths around […]

7 Quiet Career Truths That Speak Volumes

September 19, 2013 7 Truths of Career Success By Ford R. Myers, Executive Career Coach 1. The Most Qualified Candidate Does Not Necessarily Get the Job Offer Many times, candidates with lesser qualifications get job offers simply because they’ve prepared and presented themselves in a more compelling way. They “package” themselves better, with an outstanding […]

Amgen to buy Onyx Pharmaceuticals for $10.4bn

PBR Staff Writer Published 26 August 2013 Biotechnology company Amgen has reached a deal to buy all outstanding shares of California-based Onyx Pharmaceuticals for $125 per share in cash. The purchase price of the transaction that is expected to be closed by the beginning of fourth quarter is $10.4bn, or $9.7bn net of estimated Onyx […]

New Rules Spur Changes in Biopharma Recruiting

August 22, 2013 “New Rules” With Modern Hiring Practices By Angela Rose for BioSpace.com Hiring new employees to fill biopharma positions can be a complicated task. Not only must employers worry about advertising their job openings in the best places to attract the highest quality candidates, but they must also walk a fine line between […]

Johnson & Johnson completes purchase of Aragon Pharmaceuticals

PBR Staff Writer Published 20 August 2013 Johnson & Johnson has completed the acquisition of Aragon Pharmaceuticals, a pharmaceutical discovery and development company focused on drugs to hormonally-driven cancers. The Janssen Research & Development will manage compound development from Aragon’s androgen receptor antagonist program, including ARN-509, its lead androgen receptor signaling inhibitor. One of the […]

Recruiter???s Best Play to Seducing Top Talent

Attract the best candidates with Biospace Job Postings. Post a Job in minutes and find top life science candidates. October 9, 2013 Persuading Top Talent By Peter Weddle for BioSpace.com In his 2006 book Influence, Robert Cialdini identified six sources of persuasion. They are involuntary responses that come from deep within our psyche. While all […]

Breckenridge to acquire certain assets of Cypress Pharmaceuticals

PBR Staff Writer Published 12 August 2013 Pharmaceutical marketing, research and development company Breckenridge Pharmaceutical has signed a deal to acquire certain assets of Pernix Therapeutics’ subsidiary, Cypress Pharmaceuticals, for $30m. The assets included in the agreement are 11 abbreviated new drug applications (ANDAs) filed with the FDA, certain ANDAs in various stages of development, […]

Stop Social Recruiting Vultures From Stealing Your Talent

August 12, 2013 Recruiting Under the Dome By Peter Weddle for BioSpace.com The new CBS series Under the Dome explores what happens to the people of a small town when they’re completely cut off from the rest of the world. It’s a tale of endurance and intrigue, and a happy break from summer reruns on […]

Actavis takes over Palau Pharma's Albaconazole antifungal agent

PBR Staff Writer Published 07 August 2013 Actavis Specialty Brands has purchased worldwide rights for Palau Pharma’s Albaconazole antifungal agent indicated for the treatment of vulvo-vaginal candidiasis, onychomycosis and other antifungal applications. Possessing a broad-spectrum antifungal activity and a considerable safety profile, the new oral triazole Albaconazole demonstrated efficacy in patients suffering from vulvo-vaginitis, and […]

Cubist to acquire Optimer Pharmaceuticals and Trius Therapeutics

PBR Staff Writer Published 31 July 2013 Cubist Pharmaceuticals has entered into two separate agreements to acquire Optimer Pharmaceuticals and Trius Therapeutics, as part of the company’s Building Blocks of Growth strategy to strengthen its presence in acute care and hospital environments. Under a merger agreement, Cubist will acquire all of the outstanding shares of […]